Identification and characterization of PDGFRα+ mesenchymal progenitors in human skeletal muscle

Akiyoshi Uezumi(Fujita Health University Hospital), So‐ichiro Fukada(Osaka University), Naoki Yamamoto(Fujita Health University), Madoka Ikemoto‐Uezumi(National Center for Geriatrics and Gerontology), Masashi Nakatani(Fujita Health University Hospital), Mitsuhiro Morita(Fujita Health University), Asami Yamaguchi(Fujita Health University), Hirotsugu Yamada(Fujita Health University), Ichizo Nishino(National Center of Neurology and Psychiatry), Y. Hamada(Tokushima Prefectural Central Hospital), Kunihiro Tsuchida(Fujita Health University Hospital)
Cell Death and Disease
April 17, 2014
Cited by 300Open Access
Full Text

Abstract

Fatty and fibrous connective tissue formation is a hallmark of diseased skeletal muscle and deteriorates muscle function. We previously identified non-myogenic mesenchymal progenitors that contribute to adipogenesis and fibrogenesis in mouse skeletal muscle. In this study, we report the identification and characterization of a human counterpart to these progenitors. By using PDGFRα as a specific marker, mesenchymal progenitors can be identified in the interstitium and isolated from human skeletal muscle. PDGFRα(+) cells represent a cell population distinct from CD56(+) myogenic cells, and adipogenic and fibrogenic potentials were highly enriched in the PDGFRα(+) population. Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases. Our results revealed the pathological relevance of PDGFRα(+) mesenchymal progenitors to human muscle diseases and provide a basis for developing therapeutic strategy to treat muscle diseases.


Related Papers

No related papers found

Powered by citation graph analysis